Skip to main content

Allogene Therapeutics Inc. Common Stock (ALLO)

About The Company

ALLO Stock Market Logo

Allogene Therapeutics Inc is a United States-based clinical stage immuno-oncology company. It is mainly engaged in the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The company is involved in developing a pipeline of multiple allogeneic T cell product candidates utilizing validated gene editing and advanced proprietary cell manufacturing technologies. Its pipeline includes UCART19 whichis developed for the treatment of relapsed or refractory acute lymphoblastic leukemia (ALL), as well as several preclinical allogeneic CAR T therapies.

IPO Year Sector Industry
2018 Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Allogene Therapeutics Inc. (ALLO) Latest News

Company Contact & Address (ALLO)

Corporate Headquarters Phone Website
United States
+1 650 457-2700 Official ALLO Website

ALLO Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Biological Products (No Diagnostic Substances) Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ALLO

Jobs & Employment at Allogene Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Employment & Jobs at Allogene Therapeutics Inc. (ALLO)

Related & Similar Stock Symbols

BYFC Stock Market Price & News


Broadway Financial Corporation Common Stock

SDH Stock Market Price & News


Global Internet of People Inc. Ordinary Shares

FRT Stock Market Price & News


Federal Realty Investment Trust Common Stock